Japan Pharmaceuticals & Healthcare Report Q2 2018

Japan Pharmaceuticals & Healthcare Report Q2 2018

BMI View:

Sheer market size, purchasing power and the strength of the regulatory environment will maintain Japan’s position asone of the key international markets for innovative pharmaceutical products. However, an increasingly tough pricing environment,and a push towards the consumption of generic medicines, will require drugmakers to review their selling strategies in the world'sthird largest pharmaceutical market.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Region Characterised By A Mix Of Risks And Rewards
Regulatory Development
Regulatory Review
Industry Trends And Developments
Market Overview
Competitive Landscape
Company Profile
Astellas
AstraZeneca
Daiichi Sankyo
Eisai
GlaxoSmithKline
Merck & Co
Mitsubishi Tanabe
Novartis
Pfizer
Sanofi
Sawai Pharmaceutical
Takeda Pharmaceutical Company
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook